CEFPONIL 50
Description
- Contains Cefpodoxime 50 mg, a third-generation cephalosporin antibiotic
- Broad-spectrum activity against Gram-positive and Gram-negative bacteria
- Effective in treating respiratory, urinary, ear, and skin infections in children
- Bactericidal action through inhibition of bacterial cell wall synthesis
- Pediatric-friendly oral suspension with good taste and tolerability
- High oral bioavailability enhances clinical effectiveness
- To be used under medical supervision for proper dosing and safety
Composition
CEFPODOXIME-50 MG
Benefits
CEFPONIL-50 offers reliable and rapid relief from a wide range of bacterial infections in children. Its broad-spectrum coverage ensures effectiveness against both Gram-positive and Gram-negative pathogens. The oral suspension is easy to administer and well-absorbed, leading to improved compliance in young patients. CEFPONIL-50 is particularly beneficial in treating conditions such as otitis media, sinusitis, bronchitis, pharyngitis, and uncomplicated urinary tract infections. With a strong safety profile and favorable tolerability, it is a preferred antibiotic for pediatric use under a physician’s guidance.
Introduction
CEFPONIL-50 is a pediatric antibiotic formulation containing Cefpodoxime 50 mg, a third-generation cephalosporin with broad-spectrum antibacterial activity. It is commonly prescribed for treating bacterial infections in children, including respiratory tract infections, ear infections, urinary tract infections, and skin infections. Cefpodoxime works by inhibiting bacterial cell wall synthesis, leading to the destruction of the infecting organisms. CEFPONIL-50 is formulated to provide safe, effective, and well-tolerated treatment for pediatric patients, offering excellent oral bioavailability and clinical efficacy.
